Lakefront Biotherapeutics (LKFT) Change in Cash (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has 12 years of Change in Cash data on file, last reported at -$25.5 million in Q1 2026.

• Change in Cash for Q1 2026 came in at -$25.5 million, down 153.68% year-over-year; the trailing twelve-month figure through Mar 2026 was -$44.2 million (down 223.43% YoY), and the FY2025 annual result was $32.7 million, up 129.32% from the prior year.
• Change in Cash eased to -$25.5 million in Q1 2026 per LKFT's latest filing, from $28.8 million in the prior quarter.
• Over five years, Change in Cash peaked at $47.5 million in Q1 2025 and troughed at -$1.1 billion in Q1 2022.
• A 5-year average of -$138.3 million and a median of -$17.9 million in 2024 frame the typical range for Change in Cash.
• On a YoY basis, Change in Cash climbed as much as 265.08% in 2025 and fell as far as 2356.01% in 2025.
• A 5-year view of Change in Cash shows it stood at -$167.0 million in 2022, then surged by 105.38% to $9.0 million in 2023, then declined by 12.15% to $7.9 million in 2024, then surged by 265.08% to $28.8 million in 2025, then slumped by 188.41% to -$25.5 million in 2026.
• Business Quant data shows LKFT's Change in Cash at -$25.5 million in Q1 2026, $28.8 million in Q4 2025, and -$8.3 million in Q3 2025.